A Prospective Cohort Study Evaluating Risk of Local Recurrence Following Breast Conserving Surgery and Endocrine Therapy in Low Risk Luminal A Breast Cancer
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Aromatase inhibitors (Primary) ; Tamoxifen (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- Acronyms LUMINA
- 08 Sep 2021 Biomarkers information updated
- 01 Jul 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 21 Feb 2013 New trial record